# Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)

Study · id `cardio:ct-nct06092736` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06092736](<https://clinicaltrials.gov/study/NCT06092736>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06092736

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06092736. Randomized; quadruple masking; primary purpose treatment. Start 2018-12-18 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06092736, source copy `cardio:ctgov-nct06092736-2023-10-23`, retrieved 2026-11-18)
- Started: 2018-12-18 (actual) (ClinicalTrials.gov record NCT06092736, source copy `cardio:ctgov-nct06092736-2023-10-23`, retrieved 2026-11-18)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT06092736, source copy `cardio:ctgov-nct06092736-2023-10-23`, retrieved 2026-11-18)
- Completion: 2028-06-30 (anticipated) (ClinicalTrials.gov record NCT06092736, source copy `cardio:ctgov-nct06092736-2023-10-23`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06092736, source copy `cardio:ctgov-nct06092736-2023-10-23`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06092736-2023-10-23`, retrieved 2026-11-18)

## The registry's words

- Brief title: Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)
- Acronym: MAIDS
- Condition: Microvascular Angina
- Intervention (Drug): Compound Danshen Dropping Pills
- Intervention (Drug): Placebo
- Lead sponsor: Qilu Hospital of Shandong University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Microvascular and vasospastic angina (`cardio:microvascular-and-vasospastic-angina`)
- Registry lists this organization as the lead sponsor: Qilu Hospital of Shandong University (`cardio:org-qilu-hospital-of-shandong-university`)

## Provenance

Content hash: c19842248264bc0173f84d65efbdfbb033ee12b6c406ea264e5a2ef1aba3de72
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
